OpenAI is moving from generic chat to a healthcare-specific workspace, and the timing is clear: 72% of physicians now report AI use in clinical practice. The new product is free to verified U.S. physicians, NPs, PAs, and pharmacists, and OpenAI says doctors rated 99.6% of tested responses safe and accurate across 6,924 conversations.
Why it matters: OpenAI is targeting a regulated workflow where accuracy claims carry direct clinical consequences. The linked rollout cites 6,924 physician-reviewed conversations and a 99.6% safe/accurate rating in internal review.
This is less about prestige and more about control of the board. Anthropic says Vas Narasimhan, the Novartis CEO who has overseen more than 35 novel medicines, is joining through the Long-Term Benefit Trust, pushing trust-appointed directors into the majority.
JAMA highlighted on April 3, 2026 a multisite study finding AI scribe adoption across 5 academic centers was associated with 13.4 fewer EHR minutes, 16.0 fewer documentation minutes, and 0.49 more weekly visits. The effect was modest overall but larger for primary care, advanced practice clinicians, women, and heavier users.
Google Research and Google DeepMind published a real-world feasibility study of AMIE in ambulatory primary care with Beth Israel Deaconess Medical Center. The study found AMIE roughly on par with primary care physicians on overall management plans and differential diagnoses, while also documenting important practical limitations.
Google says joint research with Imperial College London and the UK’s NHS found that an experimental AI system identified 25% of interval cancers missed by conventional screening. The studies also suggest AI could reduce screening workload, while highlighting trust and calibration challenges in real clinical workflows.
At The Check Up on Mar 17, 2026, Google paired a $10 million clinician-AI education commitment with health upgrades across Search, YouTube, and Fitbit. The company is trying to combine easier-to-understand health information with more personalized wellness guidance built on consumer health data.
On March 10, 2026, Google published new results with Imperial College London and the UK NHS showing an experimental AI system identified 25% of previously missed interval cancers. A second study suggested AI could reduce screening workload by an estimated 40% when used as the second reader.
Google Research says a prospective study with Beth Israel Deaconess Medical Center found AMIE could operate with zero safety stops, strong diagnostic performance, and improved patient trust under live physician oversight. Published on March 11, 2026, the work is an early real-world test of conversational diagnostic AI inside a primary care workflow.
Google and Taiwan's NHIA said they are combining 20+ years of health data, an AI-on-DM risk model and a Gemini-powered assistant to scale diabetes screening across the national system. Google said the workflow cuts per-case processing from 20 minutes to 25 seconds and will reach a government app used by 10 million people.
NVIDIA says its latest healthcare and life sciences AI survey shows the market moving beyond experimentation and toward measurable ROI. The company reports that 70% of surveyed organizations are already using AI and 69% are using generative AI and large language models.
Element Biosciences hit the $100 genome milestone in February 2026 — a one-million-fold cost reduction from the $100M price tag of the Human Genome Project in 2000, far outpacing Moore's Law.